MiR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1346-1352

  Sun, Yan ^a   Zhao, Xiaoping ^b   Zhou, Yuhong ^a   Hu, Yu ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; Glycolysis; MiRNA; Pyruvate kinase isozyme; Warburg effect

Indexed keywords

GLUCOSE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN 2; MICRORNA; MICRORNA 124; MICRORNA 137; MICRORNA 340; POLYPYRIMIDINE TRACT BINDING PROTEIN; PYRUVATE KINASE; PYRUVATE KINASE ISOZYME M1; PYRUVATE KINASE ISOZYME M2; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; GENE; GENE EXPRESSION PROFILING; GENE SWITCHING; GLUCOSE TRANSPORT; GLYCOLYSIS; GROWTH REGULATION; HUMAN; HUMAN CELL; METABOLIC REGULATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PYRUVATE KINASE ISOZYME M1 GENE; PYRUVATE KINASE ISOZYME M2 GENE; RNA ANALYSIS; WARBURG EFFECT;

ALTERNATIVE SPLICING; CARRIER PROTEINS; COLORECTAL NEOPLASMS; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; MEMBRANE PROTEINS; MICRORNAS; PHOSPHORYLATION; PROGNOSIS; PYRUVATE KINASE; SURVIVAL ANALYSIS; THYROID HORMONES;

EID: 84866450306     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1958     Document Type: Article

References (31)

1. American Cancer Society: NY: Global Cancer Facts & Figures, 2nd edition. http://www.cancer.org/Research/CancerFactsFigures/ GlobalCancerFactsFigures/index. Accessed 2008.
2. Malafosse R, Penna C, Sa Cunha A and Nordlinger B: Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 12: 887-894, 2001.
3. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
4. Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol 4: 199-227, 2009.
5. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008.
6. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
7. Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004.
8. Jones RG and Thompson CB: Tumor suppressors and cell metabolism: a recipe for cancer growth. Gene Dev 23: 537-548, 2009.
9. Vander Heiden MG, Cantley LC and Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033, 2009.
10. Mazurek S, Boschek CB, Hugo F and Eigenbrodt E: Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15: 300-308, 2005.
11. Noguchi T, Inoue H and Tanaka T: The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 261: 13807-13812, 1986.
12. Christofk HR, Vander Heiden MG, Wu N, Asara JM and Cantley LC: Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452: 181-186, 2008.
13. Vander Heiden MG, Locasale JW, Swanson KD, et al: Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329: 1492-1499, 2010.
14. Christofk HR, Vander Heiden MG, Harris MH, et al: The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233, 2008.
15. David CJ, Chen M, Assanah M, Canoll P and Manley JL: HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463: 364-368, 2010.
16. Wang BD, Kline CL, Pastor DM, et al: Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network. Mol Cancer 9: 98, 2010.
17. Patnaik SK, Kannisto E, Knudsen S and Yendamuri S: Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36-45, 2010.
18. Silber J, Lim DA, Petritsch C, et al: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14, 2008.
19. Vanderweele DJ and Rudin CM: Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rate. Mol Cancer Res 3: 635-644, 2005.
20. Chen M, Zhang J and Manley JL: Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res 70: 8977-8980, 2010.
21. Zhang J, Guo H, Qian G, et al: MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol Cancer 9: 211, 2010.
22. Akao Y, Nakagawa Y, Hirata I, et al: Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 17: 398-408, 2010.
23. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A and Lund AH: MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 5: e8836, 2010.
24. Kaelin WG Jr and Thompson CB: Q&A: Cancer: clues from cell metabolism. Nature 465: 562-564, 2010.
25. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH and Thompson CB: Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 21: 5899-5912, 2001.
26. Ashcroft SJ, Weerasinghe LC, Bassett JM and Randle PJ: The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 126: 525-532, 1972.
27. Center MM, Jemal A, Smith RA and Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin 59: 366-378, 2009.
28. Makeyev EV, Zhang J, Carrasco MA and Maniatis T: The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27: 435-448, 2007.
29. Smith P, Al Hashimi A, Girard J, Delay C and Hebert SS: In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem 116: 240-247, 2011.
30. Werner JM, Eger K and Jurgen Steinfelder H: Comparison of the rapid pro-apoptotic effect of trans-beta-nitrostyrenes with delayed apoptosis induced by the standard agent 5-fluorouracil in colon cancer cells. Apoptosis 12: 235-246, 2007.
31. Luo W, Hu H, Chang R, et al: Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732-744, 2011.